Document is current
Any future updates will be listed below
-
Authors
Robinson, Jake
Sehly, Amro
Lan, Nick S. R.
Abraham, Abu
Dwivedi, Girish https://orcid.org/0000-0003-0717-740X
- License Information
-
More Information
Article History
Received: 13 November 2022
Accepted: 2 December 2022
First Online: 2 January 2023
Declarations
:
: NSR Lan has received research funding from Sanofi as part of a Clinical Fellowship in Endocrinology and Diabetes, education support from Amgen, Bayer, Boehringer Ingelheim and Eli Lilly, and speaker honoraria from Sanofi, Boehringer Ingelheim and Eli Lilly. GD reports paid lectures from AstraZeneca, Pfizer and Amgen not related to the topic in the manuscript and provides consultancy services and has equity interest in Artrya Ltd.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee at which the studies were conducted (GEKO Quality Activity 42595 with permission for publication) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
